Journal of Cancer Research and Treatment
ISSN (Print): 2374-1996 ISSN (Online): 2374-2003 Website: Editor-in-chief: Jean Rommelaere
Open Access
Journal Browser
Journal of Cancer Research and Treatment. 2016, 4(4), 69-72
DOI: 10.12691/jcrt-4-4-3
Open AccessMini Review

Apoptosis: Insights into Pathways and Role of p53, Bcl-2 and Sphingosine Kinases

Ahmed M. Kabel1, 2, , Almokhtar A. Adwas3, Abeer A. Elkhoely4, Mohamed Nabih Abdel-Rahman1 and Amany A. Eissa4

1Pharmacology department, Faculty of Medicine, Tanta University, Egypt

2Clinical Pharmacy department, College of Pharmacy, Taif University, Taif, KSA

3Pharmacology department, Faculty of Medicine, Zawia University, Lybia

4Pharmacology and toxicology department, Faculty of Pharmacy, Helwan University, Egypt

Pub. Date: September 05, 2016

Cite this paper:
Ahmed M. Kabel, Almokhtar A. Adwas, Abeer A. Elkhoely, Mohamed Nabih Abdel-Rahman and Amany A. Eissa. Apoptosis: Insights into Pathways and Role of p53, Bcl-2 and Sphingosine Kinases. Journal of Cancer Research and Treatment. 2016; 4(4):69-72. doi: 10.12691/jcrt-4-4-3


Apoptosis or programmed cell death is characterized by certain morphological and biochemical characteristics. It is a vital process for normal cell turnover, proper development and functioning of the immune system, embryonic development and chemical-induced cell death. Disturbances of apoptosis play a key role in many diseases including neurodegenerative diseases, autoimmune disorders and many types of cancer. The field of apoptosis research has been moving forward at a rapid rate. Although many of the key proteins that play a role in apoptosis have been identified, the molecular mechanisms of action of these proteins had not been fully elucidated. The aim of this mini-review is to provide a general overview on the process of apoptosis including pathways, regulation, the role of apoptosis in health and disease as well as the role of p53, Bcl-2 and sphingosine kinase-1 in apoptosis.

apoptosis programmed cell death cancer p53 Bcl-2 sphingosine kinase-1

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Rastogi RR, Sinha RP. Apoptosis: Molecular mechanisms and pathogenicity. EXCLI Journal 2009; 8:155-81.
[2]  Davidovich P, Kearney CJ, Martin SJ. Inflammatory outcomes of apoptosis, necrosis and necroptosis. Biol Chem. 2014; 395(10): 1163-71.
[3]  Chaabane W, User SD, El-Gazzah M, Jaksik R, Sajjadi E, Rzeszowska-Wolny J, Łos MJ. Autophagy, Apoptosis, Mitoptosis and Necrosis: Interdependence Between Those Pathways and Effects on Cancer. Arch Immunol Ther Exp 2013; 61:43-58.
[4]  Su Z, Yang Z, Xu Y, Chen Y, Yu Q. Apoptosis, autophagy, necroptosis, and cancer metastasis. Molecular Cancer 2015; 14:48.
[5]  Kalimuthu S, Se-Kwon K. Cell Survival and Apoptosis Signaling as Therapeutic Target for Cancer: Marine Bioactive Compounds. Int J Mol Sci 2013; 14: 2334-54.
[6]  Tabas I, Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nature cell biology 2011; 13(3): 184-90.
[7]  Chiarugi A, Moskowitz MA. PARP-1—a perpetrator of apoptotic cell death?.Science 2002; 297 (5579): 259-63.
[8]  Bejarano I, Espino J, González-Flores D, Casado JG, Redondo PC, Rosado JA, Barriga C, Pariente JA, Rodríguez AB. Role of Calcium Signals on Hydrogen Peroxide-Induced Apoptosis in Human Myeloid HL-60 Cells. International Journal of Biomedical Science 2009; 5(3): 246-56.
[9]  Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nature Reviews Molecular Cell Biology 2014; 15: 49-63.
[10]  Hardwick JM, Soane L. "Multiple functions of BCL-2 family proteins". Cold Spring Harb Perspect Biol 2013; 5 (2): a008722.
[11]  Pfeiffer S, Prehn JHM. The esoteric roles of Bcl-2 family proteins in glucose homeostasis and cell survival. Cell Death & Disease 2015; 6(11):e1968.
[12]  Chatterjee A, Chattopadhyay D, Chakrabarti G. MiR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis. Cell Signal 2015; 27(2): 189-203.
[13]  Shortt J, Johnstone RW. Oncogenes in Cell Survival and Cell Death. Cold Spring Harb Perspect Biol 2012; 4: a009829.
[14]  Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V, et al. Follicular lymphomas with and without translocation t (14;18) differ in gene expression profiles and genetic alterations. Blood 2009; 114: 826-34.
[15]  Goldar S, Khaniani MS, Derakhshan SM, Baradaran B. Molecular Mechanisms of Apoptosis and Roles in Cancer Development and Treatment. Asian Pac J Cancer Prev 2015; 16 (6): 2129-44.
[16]  Adwas AA, Elkhoely AA, Kabel AM, Abdel-Rahman MN, Eissa AA. Anti-cancer and cardioprotective effects of indol-3-carbinol in doxorubicin-treated mice. J Infect Chemother 2016; 22(1): 36-43.
[17]  Surget S, Khoury MP, Bourdon JC. Uncovering the role of p53 splice variants in human malignancy: a clinical perspective. OncoTargets and Therapy 2013; 7: 57-68.
[18]  Del Puerto HL, Martins AS, Milsted A, Souza-Fagundes EM, Braz GF, Hissa B, et al. Canine distemper virus induces apoptosis in cervical tumor derived cell lines. Virol J 2011; 8 (1): 334.
[19]  Niu XY, Peng ZL, Duan WQ, Wang H, Wang P. Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo. Int J Gynecol Cancer 2006; 16(2): 743-51.
[20]  Elmore S. Apoptosis: A Review of Programmed Cell Death. Toxicologic pathology 2007; 35(4): 495-516.
[21]  Hegedus A, Williamson MK, Huthoff H. HIV-1 pathogenicity and virion production are dependent on the metabolic phenotype of activated CD4+ T cells. Retrovirology 2014; 11 (1): 98.
[22]  Fuentes-González AM, Contreras-Paredes A, Manzo-Merino J, Lizano M. The modulation of apoptosis by oncogenic viruses. Virology Journal 2013; 10: 182.
[23]  Galluzzi L, Brenner C, Morselli E, Touat Z, Kroemer G. Viral Control of Mitochondrial Apoptosis. PLoS Pathog 2008; 4(5): e1000018.
[24]  Kabel AM. Tumor protein p53: Novel aspects of an old tumor marker. Journal of Cancer Research and Treatment 2015; 3 (2): 25-7.
[25]  Viatour P, Sage J. Newly identified aspects of tumor suppression by RB. Dis Model Mech. 2011; 4(5): 581-5.
[26]  Maceyka M, Spiegel S. Sphingolipid metabolites in inflammatory disease. Nature 2014; 510(7503): 58-67.
[27]  Zhang CX, He HW, Shao RG. Sphingosine kinase 1 and tumor. Yao Xue Xue Bao 2013; 48(7): 971-8.
[28]  Maceyka M, Sankala H, Hait NC, Le Stunff H, Liu H, Toman R, et al. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. Journal of Biological Chemistry 2005; 280: 37118-29.
[29]  Nayak D, Huo Y, Kwang WX, Pushparaj PN, Kumar SD, Ling EA, Dheen ST. Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. Neuroscience 2010; 166(1): 132-44.
[30]  Kapitonov D, Allegood JC, Mitchell C, Hait NC, Almenara JA, Adams JK, et al. Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts. Cancer Res 2009; 69(17): 6915-23.
[31]  Nagahashi M, Ramachandran S, Kim EY, Allegood JC, Rashid OM, Milstien S, et al. Specific inhibitor of sphingosine kinase 1 suppresses tumor-induced angiogenesis and lymphangiogenesis. Journal of the American College of Surgeons 2011; 213(3): S140.
[32]  Paugh SW, Paugh BS, Rahmani M, Kapitonov D, Almenara JA, Kordula T, et al. A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia. Blood 2008; 112(4): 1382-91.
[33]  Xu L, Zhang Y, Gao M, Wang G, Fu Y. Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells. Biochem Biophys Res Commun 2016; 472(4): 662-8.